PRIMARY STUDY
Topical cannabidiol-based treatment for psoriasis: A dual-centre randomized placebo-controlled study
Key Findings: Topical application of CBD (x 2 daily) for 12-week period induced significant improvements compared to areas treated with the placebo. No adverse effects were noted.
Type of Study: Clinical Trial
Study Sample Size: 51
Study Result: Positive
Research Location(s): Thailand
Year of Pub: 2022
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Unspecified
Route of Administration: Topical
Citation: Puaratanaarunkon T, et al. Topical cannabidiol-based treatment for psoriasis: A dual-centre randomized placebo-controlled study. J Eur Acad Dermatol Venereol. 2022; 36:e718-e720. doi: 10.1111/jdv.18215
Authors: Puaratanaarunkon T, Sittisaksomjai S, Sivapornpan N, Pongcharoen P, Chakkavittumrong P, Ingkaninan K, Temkitthawon P, Promgool T, Waranuch N, Asawanonda P
